Key facts
- Notable investors include Jumpspace Ventures, Translating Research at Melbourne.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Fluent (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Fluent (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fluent (Healthcare Technology Systems)
Developer of a high-bandwidth brain-computer interface designed for translating speech to text. The company's product is placed under the scalp for safety, uses a minimally invasive and reversible procedure, and applies context-aware artificial intelligence to decode speech, enabling individuals and healthcare markets to access safe, reliable, and advanced neural communication.
- Sector
- Healthcare
- HQ
- Sydney, Australia
- Founded
- 2025
- Employees
- 3
- Website
- fluentbci.com/
- Ownership
- Privately Held (backing)
Fluent (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fluent (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fluent (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.